These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25961853)

  • 1. Pharmacophore modeling for anti-Chagas drug design using the fragment molecular orbital method.
    Yoshino R; Yasuo N; Inaoka DK; Hagiwara Y; Ohno K; Orita M; Inoue M; Shiba T; Harada S; Honma T; Balogun EO; da Rocha JR; Montanari CA; Kita K; Sekijima M
    PLoS One; 2015; 10(5):e0125829. PubMed ID: 25961853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of potent substrate-based inhibitors of the Trypanosoma cruzi dihydroorotate dehydrogenase.
    Inaoka DK; Iida M; Hashimoto S; Tabuchi T; Kuranaga T; Balogun EO; Honma T; Tanaka A; Harada S; Nara T; Kita K; Inoue M
    Bioorg Med Chem; 2017 Feb; 25(4):1465-1470. PubMed ID: 28118956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Open Form Inducer Approach for Structure-Based Drug Design.
    Inaoka DK; Iida M; Tabuchi T; Honma T; Lee N; Hashimoto S; Matsuoka S; Kuranaga T; Sato K; Shiba T; Sakamoto K; Balogun EO; Suzuki S; Nara T; Rocha JR; Montanari CA; Tanaka A; Inoue M; Kita K; Harada S
    PLoS One; 2016; 11(11):e0167078. PubMed ID: 27893848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of Trypanosoma cruzi dihydroorotate dehydrogenase from Y strain.
    Pinheiro MP; Iulek J; Cristina Nonato M
    Biochem Biophys Res Commun; 2008 May; 369(3):812-7. PubMed ID: 18302934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system.
    Bombaça ACS; Silva LA; Chaves OA; da Silva LS; Barbosa JMC; da Silva AM; Ferreira ABB; Menna-Barreto RFS
    Biomed Pharmacother; 2021 Mar; 135():111186. PubMed ID: 33395606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.
    Ogindo CO; Khraiwesh MH; George M; Brandy Y; Brandy N; Gugssa A; Ashraf M; Abbas M; Southerland WM; Lee CM; Bakare O; Fang Y
    Bioorg Med Chem; 2016 Aug; 24(16):3849-55. PubMed ID: 27345756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
    Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
    J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
    Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
    Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi.
    Freymann DM; Wenck MA; Engel JC; Feng J; Focia PJ; Eakin AE; Craig SP
    Chem Biol; 2000 Dec; 7(12):957-68. PubMed ID: 11137818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.
    Cheleski J; Rocha JR; Pinheiro MP; Wiggers HJ; da Silva AB; Nonato MC; Montanari CA
    Eur J Med Chem; 2010 Dec; 45(12):5899-909. PubMed ID: 20965617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction.
    Inaoka DK; Sakamoto K; Shimizu H; Shiba T; Kurisu G; Nara T; Aoki T; Kita K; Harada S
    Biochemistry; 2008 Oct; 47(41):10881-91. PubMed ID: 18808149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic mechanism and catalysis of Trypanosoma cruzi dihydroorotate dehydrogenase enzyme evaluated by isothermal titration calorimetry.
    Cheleski J; Wiggers HJ; Citadini AP; da Costa Filho AJ; Nonato MC; Montanari CA
    Anal Biochem; 2010 Apr; 399(1):13-22. PubMed ID: 19932077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
    Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
    Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DHODH Hot Spots: An Underexplored Source to Guide Drug Development Efforts.
    Froes TQ; Zapata LCC; Akamine JS; Castilho MS; Nonato MC
    Curr Top Med Chem; 2021; 21(23):2134-2154. PubMed ID: 34348625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells.
    Nara T; Kamei Y; Tsubouchi A; Annoura T; Hirota K; Iizumi K; Dohmoto Y; Ono T; Aoki T
    Parasitol Int; 2005 Mar; 54(1):59-64. PubMed ID: 15710552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational study of the mechanism of half-reactions in class 1A dihydroorotate dehydrogenase from Trypanosoma cruzi.
    Silva Nde F; Lameira J; Alves CN; Martí S
    Phys Chem Chem Phys; 2013 Nov; 15(43):18863-71. PubMed ID: 24084894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.